Investors

INMODE IS A LEADING GLOBAL PROVIDER OF INNOVATIVE, ENERGY-BASED,
MINIMALLY AND NON-INVASIVE MEDICAL SOLUTIONS

InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.

Financials & Filings

STOCK PERFORMANCE

NASDAQ : INMD

PRICE

$0

CHANGE

0(0%)

VOLUME

0

Copyright Nasdaq. Latest trading day: .

Press Releases

InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth

InMode Expects Record Fourth Quarter and Full Year 2020 Results, Q4 Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Guidance of $250- $260M

InMode to Participate at the 2021 ICR Conference

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us